Bliss GVS Pharma Limited (BOM:506197)
India · Delayed Price · Currency is INR 153.70
-3.35 (-2.13%)
At close: Jan 21, 2026
Bliss GVS Pharma Employees
Bliss GVS Pharma had 966 employees as of March 31, 2025. The number of employees increased by 135 or 16.25% compared to the previous year.
Employees
966
Change (1Y)
135
Growth (1Y)
16.25%
Revenue / Employee
8.91M INR
Profits / Employee
1.13M INR
Market Cap
16.26B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 966 | 135 | 16.25% |
| Mar 31, 2024 | 831 | 68 | 8.91% |
| Mar 31, 2023 | 763 | 13 | 1.73% |
| Mar 31, 2022 | 750 | 67 | 9.81% |
| Mar 31, 2021 | 683 | 20 | 3.02% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tata Consultancy Services | 607,979 |
| Reliance Industries | 403,303 |
| Infosys | 323,578 |
| State Bank of India | 236,226 |
| HDFC Bank | 214,521 |
| ICICI Bank | 182,665 |
| Life Insurance Corporation of India | 91,606 |
| Bajaj Finance | 64,092 |
Bliss GVS Pharma News
- 2 months ago - Bliss GVS Pharma shares fall over 15% today as EBITDA drops 20% and margins shrink to 13% - Business Upturn
- 2 months ago - Bliss GVS Pharma Q2 results: Net profit up 2.5% to Rs 25.69 crore; EBITDA down 20%, margin contracts to 13% - Business Upturn
- 10 months ago - Bliss GVS Clarifies USFDA ANDA Approval for Mesalamine Suppositories - Business Upturn
- 1 year ago - Bliss GVS Pharma shares surge 4% after company receives GMP Compliance certification for its manufacturing facilities in Palghar - Business Upturn
- 1 year ago - Bliss GVS Pharma receives GMP Compliance certification for manufacturing facilities in Palghar, Maharashtra - Business Upturn